DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
08 Oct 2024
Historique:
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 8 10 2024
Statut: epublish

Résumé

Ubiquitination typically involves covalent linking of ubiquitin (Ub) to a lysine residue on a protein substrate. Recently, new facets of this process have emerged, including Ub modification of non-proteinaceous substrates like ADP-ribose by the DELTEX E3 ligase family. Here, we show that the DELTEX family member DTX3L expands this non-proteinaceous substrate repertoire to include single-stranded DNA and RNA. Although the N-terminal region of DTX3L contains single-stranded nucleic acid binding domains and motifs, the minimal catalytically competent fragment comprises the C-terminal RING and DTC domains (RD). DTX3L-RD catalyses ubiquitination of the 3'-end of single-stranded DNA and RNA, as well as double-stranded DNA with a 3' overhang of two or more nucleotides. This modification is reversibly cleaved by deubiquitinases. NMR and biochemical analyses reveal that the DTC domain binds single-stranded DNA and facilitates the catalysis of Ub transfer from RING-bound E2-conjugated Ub. Our study unveils the direct ubiquitination of nucleic acids by DTX3L, laying the groundwork for understanding its functional implications.

Identifiants

pubmed: 39377462
doi: 10.7554/eLife.98070
pii: 98070
doi:
pii:

Substances chimiques

DNA, Single-Stranded 0
Ubiquitin-Protein Ligases EC 2.3.2.27
RNA 63231-63-0
Ubiquitin 0

Banques de données

Dryad
['10.5061/dryad.rn8pk0pmv']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Cancer Research UK
ID : A29256
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A29252
Pays : United Kingdom
Organisme : Cancer Research UK Scotland Institute
ID : C596/A17196
Organisme : Cancer Research UK Scotland Institute
ID : A31287

Informations de copyright

© 2024, Dearlove, Chatrin et al.

Déclaration de conflit d'intérêts

ED, CC, LB, SA, TS, MB, BS No competing interests declared, DH D.T.H is a consultant for Triana Biomedicines

Auteurs

Emily L Dearlove (EL)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.
School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Chatrin Chatrin (C)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.
School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Lori Buetow (L)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.

Syed F Ahmed (SF)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.

Tobias Schmidt (T)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.

Martin Bushell (M)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.
School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Brian O Smith (BO)

School of Molecular Biosciences, University of Glasgow, Glasgow, United Kingdom.

Danny T Huang (DT)

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, United Kingdom.
School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH